Price Move History
- Daily moves over 5%
- 17 39 sessions, March 20, 2026 to September 14, 2026
- Largest daily move
- +40.8% close of August 19, 2026
Company Description
NEW BREAK RESOURCES (OTC: NBRKF) is classified in the gold industry within the Basic Materials sector and carries a market capitalization of $15.9M.
NBRKF has gained 26.6% over the past month. The last closing price was $0.1744.
This page collects what Stock Titan holds for NBRKF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
NEW BREAK RESOURCES (NBRKF) closed at $0.1744 on September 14, 2026. Over the past month, the price has gained 26.6%.
NBRKF Metrics & Rankings
Price returns through September 14, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
NEW BREAK RESOURCES has 7 recent news articles, with the latest published today. Of the recent coverage, 4 articles coincided with positive price movement and 1 with negative movement. View all NBRKF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in NEW BREAK RESOURCES (NBRKF) currently stands at 4.1 thousand shares, down 32.9% from the previous reporting period, representing 0.0% of the float. Since March 2026, short interest has decreased by 47.2%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for NEW BREAK RESOURCES (NBRKF) currently stands at 2.0 days, down 94.4% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 33.3% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 36.4 days.
NBRKF Company Profile & Sector Positioning
NEW BREAK RESOURCES (NBRKF) operates in the Gold industry within the broader Basic Materials sector and is listed on the OTC.